AstraZeneca reveals new growth target ahead of expectations
New target to achieve $80 billion revenue by 2030Core operating margin in mid-thirties percentageUpward earnings revisions expectedAstraZeneca (AZN) has revealed a new target to grow revenue by 75% from the $45.8 billion generated...
21 May 2024